Related Experiment Video

Updated: Aug 11, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

DNA vaccines for therapy of tuberculosis: where are we now?

Douglas B Lowrie1

  • 1National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK. dlowrie@nimr.mrc.ac.uk

Vaccine
|December 1, 2005
PubMed

Insights

DNA vaccines show promise for treating tuberculosis by stimulating the immune system against latent bacteria. However, results vary, with some studies showing enhanced pathology and others significant benefits when combined with chemotherapy.

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • Tuberculosis (TB) remains a significant global health challenge.
  • Latent TB bacteria are difficult to treat with conventional chemotherapy.
  • DNA vaccines were initially explored for TB prophylaxis.

Purpose of the Study:

  • To review the efficacy of DNA vaccines as a treatment for tuberculosis.
  • To assess the impact of DNA vaccines on both active and latent TB infections.
  • To evaluate the variability in outcomes reported across different studies.

Main Methods:

  • Review of published studies on DNA vaccines for tuberculosis in murine models.
  • Analysis of data on immune system stimulation against Mycobacterium tuberculosis.
  • Comparison of vaccine efficacy with and without combination chemotherapy.

Main Results:

  • DNA vaccines stimulated immune responses effective against latent TB bacteria in mice.
  • Reported outcomes varied widely, including enhanced pathology and negligible effects.
  • Significant additive benefits were observed when DNA vaccines were combined with chemotherapy.

Conclusions:

  • DNA vaccines demonstrate potential as a therapeutic strategy for tuberculosis, including latent infections.
  • The variability in results necessitates further research to optimize vaccine design and application.
  • Combination therapy with DNA vaccines and chemotherapy may offer a more effective treatment approach for TB.

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...